RhumbLine Advisers
CBST

RhumbLine Advisers’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

RhumbLine Advisers’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-110,655
Closed -$11.1M – 3061
2014
Q4 		$11.1M Buy
110,655
+2,514
+2% +$195K 0.03% 461
2014
Q3 		$7.17M Buy
108,141
+2,652
+3% +$174K 0.02% 591
2014
Q2 		$7.37M Sell
105,489
-2,911
-3% -$198K 0.02% 612
2014
Q1 		$7.93M Sell
108,400
-1,200
-1% -$89.5K 0.02% 597
2013
Q4 		$7.55M Buy
109,600
+41,601
+61% +$2.69M 0.02% 621
2013
Q3 		$4.32M Sell
67,999
-15,290
-18% -$924K 0.01% 881
2013
Q2 		$4.02M Buy
+83,289
New +$4.09M 0.01% 876

RhumbLine Advisers's CBST Position: Q1 2015 in Review

RhumbLine Advisers sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 110,655 shares — an estimated $11.1M sold.

RhumbLine Advisers first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $11.1M in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • RhumbLine Advisers reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • RhumbLine Advisers sold 110,655 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $11.1M.
  • RhumbLine Advisers first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • RhumbLine Advisers's CUBIST PHARMACEUTICALS INC position peaked at $11.1M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.